| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.04 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.05 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.05 |